Formyl peptide receptor 2 and heart disease.

John A Lupisella, Pravin S Shirude, Nicholas R Wurtz, Ricardo A Garcia

Seminars in immunology 2022 Jan

filter terms:

Formyl peptide receptor type 2 (FPR2) regulates the initiation and resolution phases of the inflammatory response. In the setting of heart injury and disease, dysregulated inflammation can potentiate maladaptive healing and pathological remodeling of the heart leading to cardiac dysfunction and failure. The potential to regulate and resolve adverse inflammation is postulated to improve outcome in the setting of heart disease. This review covers emerging concepts on the role of FPR2 in heart disease and strategies to activate pro-resolution processes to limit disease progression. We summarize key preclinical studies that support use of FPR2 agonists in heart disease. Finally, we briefly discuss the status of FPR2 agonists under evaluation in the clinic. Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Citation

John A Lupisella, Pravin S Shirude, Nicholas R Wurtz, Ricardo A Garcia. Formyl peptide receptor 2 and heart disease. Seminars in immunology. 2022 Jan;59:101602